FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

358611000001101: Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16813301000001111 Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
37757901000001112 Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Is a Generic Tri-Adcortyl Otic ointment true Inferred relationship Existential restriction modifier
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Has active ingredient Neomycin sulfate false Inferred relationship Existential restriction modifier
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Has active ingredient Nystatin true Inferred relationship Existential restriction modifier
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Has active ingredient Gramicidin true Inferred relationship Existential restriction modifier
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Has active ingredient Triamcinolone acetonide false Inferred relationship Existential restriction modifier
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) VMP prescribing status (attribute) Never valid to prescribe as a VMP true Inferred relationship Existential restriction modifier
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Is a Tri-Adcortyl true Inferred relationship Existential restriction modifier
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Neomycin true Inferred relationship Existential restriction modifier
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Has specific active ingredient Nystatin true Inferred relationship Existential restriction modifier
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Has specific active ingredient Neomycin sulfate true Inferred relationship Existential restriction modifier
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Has specific active ingredient Triamcinolone acetonide true Inferred relationship Existential restriction modifier
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Has specific active ingredient Gramicidin true Inferred relationship Existential restriction modifier
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Has active ingredient Triamcinolone true Inferred relationship Existential restriction modifier
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Has active ingredient Neomycin true Inferred relationship Existential restriction modifier
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Has dispensed dose form Ointment true Inferred relationship Existential restriction modifier
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Has basis of strength substance Neomycin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 10 gram Is pack of False Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Inferred relationship Existential restriction modifier
Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) 10 gram Has AMP True Tri-Adcortyl Otic ointment (Bristol-Myers Squibb Pharmaceuticals Limited) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start